"Wealth follows health, and it ain't the other way around," said John Lechleiter, the CEO and chairman of the drug maker Eli Lilly & Co.
Mr. Lechleiter explains, "There's no better investment that we can make than in biomedical research and in our health. I believe this will be the biomedical century. We'll look back a hundred years from now and say the 20th century was the century of chemistry and physics, and the 21st century was the century of biomedicine."
"The challenge or the opportunity we have is that never before has the science and our knowledge base been riper for exploitation," Mr. Lechleiter adds during his interview with The Wall Street Journal.
Read the complete story by clicking to http://online.wsj.com